Abstract
Pulse-treatment of U-937 human promonocytic cells with cadmium chloride followed by recovery caused caspase-9/caspase-3-dependent, caspase-8-independent apoptosis. However, pre-incubation with the glutathione (GSH)-suppressing agent DL-buthionine-(S,R)-sulfoximine (cadmium/BSO), or co-treatment with H2O2 (cadmium/H2O2), switched the mode of death to caspase-independent necrosis. The switch from apoptosis to necrosis did not involve gross alterations in Apaf-1 and pro-caspase-9 expression, nor inhibition of cytochrome c release from mitochondria. However, cadmium/H2O2-induced necrosis involved ATP depletion and was prevented by 3-aminobenzamide, while cadmium/BSO-induced necrosis was ATP independent. Pre-incubation with BSO increased the intracellular cadmium accumulation, while co-treatment with H2O2 did not. Both treatments caused intracellular peroxide over-accumulation and disruption of mitochondrial transmembrane potential (ΔΨm). However, while post-treatment with N-acetyl-L-cysteine or butylated hydroxyanisole reduced the cadmium/BSO-mediated necrosis and ΔΨm disruption, it did not reduce the effects of cadmium/H2O2. Bcl-2 over-expression, which reduced peroxide accumulation without affecting the intracellular GSH content, attenuated necrosis generation by cadmium/H2O2 but not by cadmium/BSO. By contrast, AIF suppression, which reduced peroxide accumulation and increased the GSH content, attenuated the toxicity of both treatments. These results unravel the existence of two different oxidation-mediated necrotic pathways in cadmium-treated cells, one of them resulting from ATP-dependent apoptosis blockade, and the other involving the concurrence of multiple regulatory factors.
Similar content being viewed by others
References
Stoeppler M. Cadmium. In: Merian A, ed. Metals and Their Compounds in the Environment. Occurrence, Analysis, and Biological Relevance. Weinheim, New York, Basel, Cambridge: VCH, 1991: 803–851.
Li M, Kondo T, Zhao QL, et al. Apoptosis induced by cadmium in human lymphoma U937 cells through Ca2+-calpain and caspase-mitochondria-dependent pathways. J Biol Chem 2000; 275: 39702–39709.
Kondoh M, Araragi S, Sato K, Higashimoto M, Takiguchi M, Sato M. Cadmium induces apoptosis partly via caspase-9 activation in HL-60 cells. Toxicology 2002; 170: 111–117.
Shih CM, Wu JS, Ko WC, et al. Mitochondria-mediated caspase-independent apoptosis induced by cadmium in normal human lung cells. J Cell Biochem 2003; 89: 335–347.
López E, Figueroa S, Oset-Gasque MJ, González MP. Apoptosis and necrosis: Two distinct events induced by cadmium in cortical neurons in culture. Br J Pharmacol 2003; 138: 901–911.
Somji S, Garrett SH, Sens MA, Gurel V, Sens DA. Expression of metallothionein isoform 3 (MT-3) determines the choice between apoptotic or necrotic cell death in Cd2+-exposed human proximal tubule cells. Toxicol Sci 2004; 8: 358–366.
Bailey HH. L-S,R-buthionine sulfoximine: Historical development and clinical issues. Chem Biol Interact 1998; 111–112: 239–254.
Galán A, Troyano A, Vilaboa NE, Fernández C, de Blas E, Aller P. Modulation of the stress response during apoptosis and necrosis induction in cadmium-treated U-937 human promonocytic cells. Biochim Biophys Acta 2001; 1538: 38–46.
McGowan AJ, Bowie AG, O’Neill LA, Cotter TG. The production of a reactive oxygen intermediate during the induction of apoptosis by cytotoxic insult. Exp Cell Res 1998; 238: 248–256.
Lee YJ, Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999; 274: 19792–19798.
Ramos AM, Fernández C, Amrán D, Sancho P, de Blas E, Aller P. Pharmacological inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Blood 2005; 105: 4013–4020.
Dickinson DA, Forman HJ. Cellular glutathione and thiols metabolism. Biochem Pharmacol 2002; 64: 1019–1026.
Sundström C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565–577.
Renvoize C, Roger R, Moulian N, Bertoglio J, Bréard J. Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis. J Immunol 1997; 159: 126–134.
Troyano A, Fernández C, Sancho P, de Blas E, Aller P. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation. J Biol Chem 2001; 276: 47107–47115.
Bellosillo B, Villamor N, López-Guillermo A, et al. Spontaneous and drug-induced apoptosis mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukaemia. Blood 2002; 100: 1810–1816.
Sancho P, Troyano A, Fernández C, de Blas E, Aller P. Differential effects of catalase on apoptosis induction in human promonocytic cells. Relationships with heat-shock protein expression. Mol Pharmacol 2003; 63: 581–589.
Amrán D, Sancho P, Fernández C, et al. Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation. Biochim Biophys Acta 2005; 1743: 269–279.
Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell death. Pharmacol Therapeut 2001; 92: 57–70.
Hyslop PA, Hinshaw DB, Halsey WA Jr, et al. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 1988; 263: 1665–1675.
Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997; 57: 1835–1840.
Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481–1486.
Filipovic DM, Meng X, Reeves WB. Inhibition of PARP prevents oxidant-induced necrosis but not apoptosis in LLC-PK1 cells. Am J Physiol 1999; 277: F428–F436.
Cole KK, Pérez-Polo JR. Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H2O2 injury. J Neurochem 2002; 82: 19–29.
Klaassen CD, Bracken WM, Dudley RE, Goering PL, Hazelton GA, Hjelle JJ. Role of sulfhydryls in the hepatotoxicity of organic and metallic compounds. Fundam Appl Toxicol 1985; 5: 806–815.
Li M, Xia T, Jiang CS, Li L, Fu J, Zhou Z. Cadmium directly induced the opening of membrane permeability pore of mitochondria which possibly involved in cadmium-triggered apoptosis. Toxicology 2003; 194: 19–33.
Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–251.
Kane DJ, Sarafian TA, Anton R, et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993; 262: 1274–1277.
Shimizu S, Eguchi Y, Kamiike W, et al. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 1996; 12: 2045–2050.
Guénal I, Sidoti-de Fraisse C, Gaumer S, Mignotte B. Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene 1997; 15: 347–360.
Denecker G, Vercammen D, Steemans M, et al. Death receptor-induced apoptotic and necrotic cell death: Differential role of caspases and mitochondria. Cell Death Differ 2001; 8: 829–840.
Susin S, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441–446.
Miramar MD, Costantini P, Ravagnan L, et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 2001; 276: 16391–16398.
Vahsen N, Candé C, Brière JJ, et al. AIF deficiency compromises oxidative phosphorylation. EMBO J 2004; 23: 4679–4689.
Klein JA, Longo-Guess CM, Rossmann MP, et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002; 419: 367–374.
Candé C, Vahsen N, Métivier D, et al. Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J Cell Sci 2004; 117: 4461–4468.
Saikumar P, Dong Z, Patel Y, et al. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998; 17: 3401–3415.
Single B, Leist M, Nicotera P. Differential effects of bcl-2 on cell death triggered under ATP-depleting conditions. Exp Cell Res 2001; 262: 8–16.
Cossarizza A, Franceschi C, Monti D, et al. Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: The role of mitochondria. Exp Cell Res 1995; 220: 232–240.
Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 1999; 18: 7719–7730.
Barros LF, Hermosilla T, Castro J. Necrotic volume increase and the early physiology of necrosis. Comp Biochem Physiol A Mol Integr Physiol 2001; 130: 401–409.
Maeda H, Hori S, Ohizumi H, et al. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine. Cell Death Differ 2004; 89: 737–746.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sancho, P., Fernández, C., Yuste, V.J. et al. Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress. Apoptosis 11, 673–686 (2006). https://doi.org/10.1007/s10495-006-5879-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-006-5879-3